Case Reports in Gastrointestinal Medicine

Case Reports in Gastrointestinal Medicine / 2020 / Article

Case Report | Open Access

Volume 2020 |Article ID 8509591 | https://doi.org/10.1155/2020/8509591

Hafsa Abbas, Harish Patel, Ahmed Baiomi, Masooma Niazi, Trupti Vakde, Sridhar Chilimuri, "A Rare Case of Splenic Pneumocystis jirovecii in a HIV-Positive Patient", Case Reports in Gastrointestinal Medicine, vol. 2020, Article ID 8509591, 5 pages, 2020. https://doi.org/10.1155/2020/8509591

A Rare Case of Splenic Pneumocystis jirovecii in a HIV-Positive Patient

Academic Editor: Yoshihiro Moriwaki
Received25 Nov 2019
Revised02 Feb 2020
Accepted18 Mar 2020
Published10 Jun 2020

Abstract

Introduction. Human immunodeficiency virus (HIV) positive individuals with the CD4 count less than 200 cells/mm3 are at risk for opportunistic infections. Pneumocystis jirovecii, a fungal pathogen, is a common cause of opportunistic infections with predominantly pulmonary involvement. Disseminated P. jiroveciii infection presenting with hepatosplenic lesion is extremely rare. Case Summary. A 31-year-old male with HIV with and acquired immunodeficiency syndrome (AIDS) presented with diarrhea for 3 weeks. He had splenomegaly and inguinal lymphadenopathy on physical examination. Laboratory parameters revealed anemia and hypoalbuminemia, while stool studies for infectious etiology and fecal leucocyte were negative. Computed tomography (CT) of the chest and abdomen depicted consolidation of the lungs and a large splenic mass. He underwent fiberoptic bronchoscopy with transbronchial biopsy which was consistent with P. jirovecii pneumonia. He also had a ultrasound-guided core biopsy of the splenic mass which revealed necrotizing granulomas with Pneumocystis jirovecii infection on Grocott-Gomori's methenamine silver (GMS) stain and was initiated on treatment for P. jirovecii with sulfamethoxazole with trimethoprim. Conclusion. Malignancy and atypical infection are key differentials in patients presenting with hepatosplenic lesions. HIV positive patients are at increased risk of AIDS-related lymphoma. Tissue diagnosis is often required for further evaluation. Disseminated P. jirovecii presenting with splenic mass and liver lesion is extremely rare.

1. Introduction

An opportunistic infection is defined as an infection affecting individuals with weakened immune system. Human immunodeficiency virus (HIV) positive patients with CD4 count below 200/mm3 are at high risk of the opportunistic infection [1]. Patients with HIV are at increased risk of lymphoma and often present with the extranodal disease with tumor burden [2]. Acquired immune deficiency syndrome (AIDS) related lymphoma is common in HIV-positive patients, especially in those with lower CD4 count [3].

Pneumocystis jirovecii, previously known as Pneumocystis carinii, is a common opportunistic fungal pathogen mostly affecting immunocompromised individuals [4, 5]. Pulmonary infection is the most common presentation for P. jirovecii infection and is often life-threatening [57]. Pharmacological prophylaxis is recommended in patients with CD4 count below 200/mm3. However, patients with a high HIV viral load in the absence of antimicrobial prophylaxis can present with a disseminated extrapulmonary infection [4, 8]. Extrapulmonary manifestation is exceedingly rare and requires a thorough evaluation to exclude other etiologies such as lymphoma or other malignancies.

We report a case of disseminated pneumocystis in a patient with AIDS presenting with splenic mass and liver nodules along with concurrent P. jirovecii pneumonitis. On our review of literature, splenic involvement of pneumocystis is very rare, and only a few cases have been reported so far [4, 912].

2. Case Summary

A 31-year-old man was evaluated in the emergency room (ER) of our institution for persistent diarrhea of 3 weeks duration. He also reported abdominal pain along with lightheadedness. He described the abdominal pain as vague, diffuse, nonradiating, and mild in intensity without any precipitating or relieving factors. He reported up to 10 episodes of watery diarrhea which did not contain any blood. He also complained of fever and dysuria. About 3 weeks before the current presentation, the patient had presented to the ER with dysuria, abdominal pain, and intermittent diarrhea. At that time he was admitted and treated for a urinary tract infection (UTI) with ciprofloxacin and later discharged home. As per patient, his diarrhea had worsened after taking the antibiotics and had presented with the current symptoms. There was no nausea, vomiting, constipation, fever, and early satiety or appetite changes. He had a prior history of HIV/AIDS, had not been adherent to antiretroviral therapy or PCP prophylaxis. He had a high viral load and low CD4 count.

He was a current smoker and admitted smoking 4 or more cigarettes per day but denied using alcohol except on social occasions or illicit drugs. He did not have a family history of liver, stomach, or colon cancer. His medications included acetaminophen and ciprofloxacin.

On examination, he was found to have a temperature of 39.1°C, blood pressure of 108/52 mmHg, a pulse rate of 99 beats per minute, and a respiratory rate of 16 breaths per minute. The patient was alert, fully oriented, and communicative. The abdomen was scaphoid, nontender, and nondistended with normal bowel sounds. There was no palpable hepatomegaly; however, the spleen was palpable. Shotty cervical and inguinal lymph nodes were palpated. The rest of the physical examination was unremarkable.

Routine laboratory tests showed a hemoglobin level of 8 g/dL, white blood cell count of 3.7 k/uL, serum potassium level of 3.4 mEq/L, and albumin level of 1.7 g/dL. Stool studies including Clostridium difficile cytotoxin, fecal leucocyte stain, and fecal fat were negative. His blood and stool cultures were negative for the growth of Mycobacterium avium complex. A chest X-ray revealed a right lower lobe consolidation and bilateral pleural effusions. The patient was initiated on broad spectrum antibiotics for hospital-acquired infection. A CT of the chest was done as a part of workup revealed moderate right and small left pleural effusions, consolidation in the dependent lung bases, nodular opacities in both lungs, some cavitary in nature, and patchy ground glass opacity in both lungs (Figure 1). Sputum for acid-fast bacilli (AFB) was negative, ruling out pulmonary tuberculosis. CT abdomen and pelvis done for chronic diarrhea and abdominal pain revealed a hypodense lesion within the cephalad aspect of the spleen, a 6.7 cm splenic mass with adjacent small nodule, multiple hypodense hepatic lesions, measuring up to 12 mm in diameter, and mild ascites in the upper abdomen (Figure 2). Magnetic resonance imaging (MRI) abdomen showed a heterogeneous lesion within the upper pole of the spleen measuring 5.2 × 4.3 cm in size with absent enhancement centrally, with some enhancement along the peripheral aspect of the lesion, suggesting central necrosis (Figure 3). He underwent an ultrasound-guided core biopsy with an 18-gauge (18G) needle. Two core biopsies were obtained for histologic analysis of the splenic mass. The histopathology revealed necrotizing granulomas on hematoxylin and eosin stain (Figures 4 and 5) with Pneumocystis jirovecii infection on Grocott-Gomori’s methenamine silver (GMS) stain (Figures 6(a) and 6(b)). A fiberoptic bronchoscopy with transbronchial biopsy was also done revealing P. jirovecii pneumonia, while bronchoalveolar lavage was negative for malignant cells. His alpha fetoprotein (AFP) level was 3.2 ng/ml. Results of the rest of the laboratory parameters are given in Table 1. The patient was started on sulfamethoxazole with trimethoprim, and no steroids were given. Antiretroviral therapy was not started at the time of discharge due to concerns over IRS (immune reconstitution syndrome). He continued to follow-up at our hospital as an outpatient.


ParameterInitial laboratory resultsReference range

Hemoglobin (g/dL)8.712–16
Hematocrit (%)26.642–51
White blood cell count (per mm3)3.74.8–10.8
Platelet count (k/μL)344150–400
Sodium (mEq/L)135135–145
Potassium (mEq/L)3.43.5–5.0
HCO3 (mEq/L)1924–30
BUN (mg/dl)66–20
Creatinine (mg/dL)10.5–1.5
Glucose (mg/dL)6770–120
Lactic acid (mmol/L)1.50.5–1.6
AST (mg/dL)749–48
ALT (mg/dL)635–40
Total bilirubin/direct (mg/dL)0.20.2–1.2
Alkaline phosphatase (U/L)8353–141
Albumin (g/dL)1.83.2–4.8
Alpha fetoprotein (AFP) (ng/mL)3.2<10
Hepatitis A IgMNegativeNegative
Hepatitis B core total antibodyNegativeNegative
Hepatitis B surface antibodyPositiveNegative
Hepatitis B surface antigenNegativeNegative
Hepatitis C antibodyNegativeNegative
HIV RNA PCR (copies/mL)206,000Not detectable
Absolute CD4 cells<20490–1740

3. Discussion

There are a wide array of differentials for a patient presenting with splenic lesion [13]. Angiosarcoma, lymphoma, hemangioendothelioma, and metastasis are the common malignant etiologies of the splenic lesion. MRI of the splenic lesion with and without gadolinium enhancement can assist in further characterization, but is not diagnostic [14]. Image-guided percutaneous biopsy of the spleen with 18G needle is safe and is a favorable alternative to diagnostic splenectomy [15]. It is essential to characterize the vascular pattern of splenic lesion prior to biopsy. Given the risk of malignancy, our patient required splenic biopsy.

Before AIDS pandemic, there were sporadic cases of P. jirovecii pneumonia in individuals with immunosuppression due to corticosteroids or chemotherapy [4, 16]. Now, it is the most common respiratory opportunistic infection in AIDS patients. Pneumonia or interstitial pneumonitis is the most common presentation of P. jirovecii in HIV/AIDS patients [12]. The first case of fatal extrapulmonary pneumocystis was reported in 1960 [17]. Extrapulmonary or disseminated pneumocystis infection is uncommon, about 0.5% to 2.5% in patients with AIDS [18, 19] but has been described and well documented [8, 2027].

Disseminated pneumocystis has a highly variable pattern of tissue involvement. It can involve the spleen, liver, gastrointestinal tract [22], skin [28], heart, bone marrow with lymph nodes [8], kidneys, thyroid, and skeletal muscle [24]. The clinical presentation has a wide array of symptoms. Diffuse organ involvement can result in systemic symptoms, whereas local involvement can produce local symptoms, such as isolated involvement of the small intestine [29] causing acute abdomen and thyroid disease, causing left-sided neck swelling and dysphagia [30]. Pneumocystis of the liver has been reported to be associated with hypoalbuminemia, ascites, and anasarca [9, 31, 32].

Splenic involvement of pneumocystis can present with left upper quadrant pain, splenic mass, thrombocytopenia, and splenomegaly [33]. Typical features of splenic pneumocystis on CT abdomen are multiple hypodense lesions with punctate or rim-like calcifications [9, 34].

Our patient with AIDS had presented with abdominal pain, and imaging revealed hypodense lesions in both spleen and liver. Splenic biopsy and transbronchial biopsy revealed pneumocystis consistent with disseminated pneumocystis. Disseminated P. jirovecii was diagnosed with splenic and transbronchial lung biopsy, and hence, hepatic biopsy was not required. Although the liver lesions were not biopsied but the clinical presentation of our patient including ascites, hypoalbuminemia and hypodense liver lesions on CT is similar to prior cases reporting hepatic pneumocystis.

4. Conclusion

Patients with HIV and AIDS presenting with hepatosplenic mass have a wide array of differentials with opportunistic infection and the malignancy being the most common etiology. Image-guided splenic tissue aspiration is required for the diagnosis. As presented in the index case, disseminated P. jirovecii infection can be a possible etiology for the splenic mass.

The patient provided informed consent for publication of this report and the accompanying images.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

References

  1. B. C. Zanoni and R. T. Gandhi, “Update on opportunistic infections in the era of effective antiretroviral therapy,” Infectious Disease Clinics of North America, vol. 28, no. 3, pp. 501–518, 2014. View at: Publisher Site | Google Scholar
  2. K. L. Grogg, R. F. Miller, and A. Dogan, “HIV infection and lymphoma,” Journal of Clinical Pathology, vol. 60, no. 12, pp. 1365–1372, 2007. View at: Google Scholar
  3. A. Levine, “Acquired immunodeficiency syndrome-related lymphoma,” Blood, vol. 80, no. 1, pp. 8–20, 1992. View at: Publisher Site | Google Scholar
  4. C. B. O’Neal and S. C. Ball, “Splenic pneumocystosis: an a typical presentation of extrapulmonary Pneumocystis infection,” AIDS Read, vol. 18, no. 10, pp. 503–508, 2008. View at: Google Scholar
  5. J. Truong and J. V. Ashurst, Pneumocystis (Carinii) Jirovecii Pneumonia, StatPearls, Treasure Island, FL, USA, 2019.
  6. C. A. Mecoli, D. Saylor, A. C. Gelber, and L. Christopher-Stine, “Pneumocystis jirovecii pneumonia in rheumatic disease: a 20-year single-centre experience,” Clinical and Experimental Rheumatology, vol. 35, no. 4, pp. 671–673, 2019. View at: Google Scholar
  7. A. Ricciardi, E. Gentilotti, L. Coppola et al., “Infectious disease ward admission positively influences P. jirovecii pneumonia (PjP) outcome: a retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients,” PLoS One, vol. 12, no. 5, Article ID e0176881, 2017. View at: Publisher Site | Google Scholar
  8. A. J. Kallen and M. R. Wallace, “A typical Pneumocystis carinii infection in AIDS,” Southern Medical Journal, vol. 91, no. 8, pp. 759-760, 1998. View at: Publisher Site | Google Scholar
  9. P. F. Rockley, C. M. Wilcox, M. Moynihan, K. Hewan-Lowe, and D. A. Schwartz, “Splenic infection simulating lymphoma: an unusual presentation of disseminated Pneumocystis carinii infection,” Southern Medical Journal, vol. 87, no. 4, pp. 530–536, 1994. View at: Publisher Site | Google Scholar
  10. A. Galimberti, E. Morandi, G. Giani et al., “Pneumocystosis of splenic localization in the course of HIV infection: a new indication for splenectomy: description of a case,” Annali Italian di Chirugia, vol. 68, no. 4, pp. 559–562, 1997. View at: Google Scholar
  11. A. Grasland, J. Pouchot, C. Michon, A. Hertig, A. Simonpoli, and P. Vinceneux, “Splenic pneumocystosis disclosing extrapulmonary pneumocystosis of fatal outcome,” Annales de Medecine Interne (Paris), vol. 148, no. 2, pp. 184-185, 1997. View at: Google Scholar
  12. C. J. Harvey, A. G. Rockall, W. R. Lees, and R. F. Miller, “Splenic pneumocystosis in AIDS: unusual ultrasound appearances,” International Journal of STD & AIDS, vol. 8, no. 5, pp. 342–344, 1997. View at: Publisher Site | Google Scholar
  13. H.-J. Lee, J. W. Kim, J. H. Hong et al., “Cross-sectional imaging of splenic lesions: RadioGraphics fundamentals | online presentation,” RadioGraphics, vol. 38, no. 2, pp. 435-436, 2018. View at: Publisher Site | Google Scholar
  14. A. Luna, R. Ribes, P. Caro, L. Luna, E. Aumente, and P. R. Ros, “MRI of focal splenic lesions without and with dynamic gadolinium enhancement,” American Journal of Roentgenology, vol. 186, no. 6, pp. 1533–1547, 2006. View at: Publisher Site | Google Scholar
  15. M. D. F. McInnes, A. Z. Kielar, and D. B. Macdonald, “Percutaneous image-guided biopsy of the spleen: systematic review and meta-analysis of the complication rate and diagnostic accuracy,” Radiology, vol. 260, no. 3, pp. 699–708, 2011. View at: Publisher Site | Google Scholar
  16. P. D. Walzer, D. P. Perl, D. J. Krogstad, P. G. Rawson, and M. G. Schultz, “Pneumocystis cariniiPneumonia in the United States,” Annals of Internal Medicine, vol. 80, no. 1, pp. 83–93, 1974. View at: Publisher Site | Google Scholar
  17. C. D. Anderson and H. J. Barrie, “Fatal pneumocystis pneumonia in an adult: report of a case,” American Journal of Clinical Pathology, vol. 34, no. 4, pp. 365–370, 1960. View at: Publisher Site | Google Scholar
  18. M. C. Raviglione, “Extrapulmonary pneumocystosis: the first 50 cases,” Clinical Infectious Diseases, vol. 12, no. 6, pp. 1127–1138, 1990. View at: Publisher Site | Google Scholar
  19. E. E. Telzak, R. J. Cote, J. W. M. Gold, S. W. Campbell, and D. Armstrong, “Extrapulmonary Pneumocystis carinii infections,” Clinical Infectious Diseases, vol. 12, no. 3, pp. 380–386, 1990. View at: Publisher Site | Google Scholar
  20. A. D. Abati, L. Opitz, C. Brones, D. E. Burstein, and L. Gallo, “Cytology of extrapulmonary Pneumocystis carinii infection in the acquired immunodeficiency syndrome,” Acta Cytologica, vol. 36, no. 3, pp. 440–444, 1992. View at: Google Scholar
  21. C. Bazin, P. Hazera, A. Greder et al., “Extrapulmonary and disseminated pneumocystosis in HIV infection,” Presse Medicale, vol. 22, no. 4, pp. 161–165, 1993. View at: Google Scholar
  22. E. Bierhoff, A. Tran, E. Pakos, J. Rockstroh, and U. Pfeifer, “Perforation of the small intestine in a patient with disseminated Pneumocystis carinii infection in AIDS,” General & Diagnostic Pathology, vol. 141, no. 3-4, pp. 255–260, 1996. View at: Google Scholar
  23. O. J. Cohen and M. Y. Stoeckle, “Extrapulmonary Pneumocystis carinii infections in the acquired immunodeficiency syndrome,” Archives of Internal Medicine, vol. 151, no. 6, pp. 1205–1214, 1991. View at: Publisher Site | Google Scholar
  24. G. Z. Panos, I. Karydis, S. E. Velakoulis, and M. E. Falagas, “Multi-skeletal Pneumocystis jiroveci (carinii) in an HIV-seropositive patient,” International Journal of STD & AIDS, vol. 18, no. 2, pp. 134–137, 2007. View at: Publisher Site | Google Scholar
  25. B. Terris, C. Marche, and F. Potet, “Extra-pulmonary pneumocystosis in the course of AIDS: report of a case,” Annales de Pathologie, vol. 16, no. 1, pp. 41–44, 1996. View at: Google Scholar
  26. E. Valdes, F. Borzoni, D. Onnis, S. Piras, A. Vespa, and C. Varsi, “Disseminated Pneumocystis carinii infection: clinico-pathologic findings in an AIDS patient,” Pathologica, vol. 86, no. 6, pp. 659–664, 1994. View at: Google Scholar
  27. T. Wakabayashi, S. Oka, K. Shimada, I. Nakano, T. Iwatsubo, and S. Mori, “Disseminated Pneumocystis carinii infection in a hemophiliac patient with acquired immunodeficiency syndrome,” Virchows Archiv A Pathological Anatomy and Histopathology, vol. 42, no. 4, pp. 262–266, 1994. View at: Publisher Site | Google Scholar
  28. D. L. Bundow and D. M. Aboulafia, “Skin involvement with Pneumocystis despite dapsone prophylaxis: a rare cause of skin nodules in a patient with AIDS,” The American Journal of the Medical Sciences, vol. 313, no. 3, pp. 182–186, 1992. View at: Publisher Site | Google Scholar
  29. T. R. Carter, P. H. Cooper, W. A. Petri, C. K. Kim, P. D. Walzer, and R. L. Guerrant, “Pneumocystis carinii infection of the small intestine in a patient with acquired immune deficiency syndrome,” American Journal of Clinical Pathology, vol. 89, no. 5, pp. 679–683, 1988. View at: Publisher Site | Google Scholar
  30. J. E. Gallant, R. E. Enriquez, K. L. Cohen, and L. W. Hammers, “Pneumocystis carinii thyroiditis,” The American Journal of Medicine, vol. 84, no. 2, pp. 303–306, 1988. View at: Publisher Site | Google Scholar
  31. R. B. Poblete, K. Rodriguez, R. T. Foust, K. R. Reddy, and M. J. Saldana, “Pneumocystis carinii hepatitis in the acquired immunodeficiency syndrome (AIDS),” Annals of Internal Medicine, vol. 110, no. 9, pp. 737-738, 1989. View at: Publisher Site | Google Scholar
  32. W. A. Hagopian and J. S. Huseby, “Pneumocystis hepatitis and choroiditis despite successful aerosolized pentamidine pulmonary prophylaxis,” Chest, vol. 96, no. 4, pp. 949–951, 1989. View at: Publisher Site | Google Scholar
  33. V. A. Pilon, R. M. Echols, J. S. Celo, and S. L. Elmendorf, “Disseminated Pneumocystis carinii infection in AIDS,” The New England Journal of Medicine, vol. 316, no. 22, pp. 1410-1411, 1987. View at: Publisher Site | Google Scholar
  34. E. K. Fishman, D. Magid, and J. E. Kuhlman, “Pneumocystis carinii involvement of the liver and spleen,” Journal of Computer Assisted Tomography, vol. 14, no. 1, pp. 146–148, 1990. View at: Publisher Site | Google Scholar

Copyright © 2020 Hafsa Abbas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views230
Downloads155
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.